Opportunity Information: Apply for PA 13 079
Apply for PA 13 079
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Behavioral Integrative Treatment Development Program (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jan 9, 2013 and posted on Jan 9, 2013.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Small businesses For profit organizations other than small businesses Private institutions of higher education City or township governments Public and State controlled institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Behavioral Integrative Treatment Development Program (R03), Funding Opportunity Number PA-13-079, was a discretionary National Institutes of Health (NIH) grant opportunity designed to support small, clearly defined research projects that could be finished within a two-year period. Using the NIH R03 mechanism, the program emphasized early-stage or targeted studies rather than large, multi-year clinical trials. The maximum award amount listed for this opportunity was $100,000, and there was no cost sharing or matching requirement, making it particularly suited for pilot work, intervention development, and other preparatory research that can establish a foundation for later, larger-scale grants.
The central goal of the announcement was to stimulate research on behavioral interventions or integrated approaches that combine behavioral strategies with other modalities, such as pharmacological treatment. The scientific scope focused on several high-priority public health areas: drug abuse (including common co-occurring conditions), prevention of HIV acquisition or transmission among people in drug abuse treatment, improving adherence to drug abuse treatment and to HIV or addiction medications, and interventions relevant to chronic pain. In practice, the FOA sought projects that build or refine interventions intended to change behavior and improve health outcomes in these domains, particularly where adherence, engagement, or implementation challenges are common.
A key feature of the FOA was its emphasis on Stage I behavioral intervention development. The announcement highlighted several example project types, including Stage I intervention generation (the creation and initial shaping of new interventions) and Stage I pilot or feasibility studies (early testing to determine whether an approach is practical, acceptable, and promising). Importantly, the FOA indicated that these early-stage projects should incorporate work on potential moderators, mediators, and mechanisms of change. In other words, applicants were encouraged not only to test whether an intervention might work, but also to investigate for whom it works best, under what conditions it works, and how it produces change. The FOA also encouraged Stage I studies that adapt or refine drug abuse treatment or adherence interventions for use in primary care settings, reflecting an interest in making interventions more relevant to real-world healthcare environments. Another priority area was strengthening the impact and practicality of interventions by improving their implementability, including through creative uses of technology or other strategies that could increase reach, consistency, or scalability.
Eligibility under PA-13-079 was broad and included many organization types across the public, private, nonprofit, and educational sectors. Eligible applicants included federal, state, county, city, and township governments; special district governments; public and private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); small businesses and other for-profit organizations (including those that are not small businesses); and Native American tribal governments and organizations (including federally recognized tribal governments and other tribal entities). The FOA also explicitly noted eligibility for a range of mission- or population-focused institutions and organizations, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, U.S. territories or possessions, and regional organizations. Notably, non-U.S. entities were allowed to apply, including foreign organizations and foreign institutions, and foreign components as defined by NIH policy were permitted, which broadened the opportunity to international applicants and collaborations.
From a timeline standpoint, the opportunity was posted and created on January 9, 2013, with an original and final closing date of January 7, 2016, and it was archived on February 7, 2016. The FOA’s official listing associated it with CFDA numbers 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs), reflecting the NIH research areas it supported. The full announcement was made available through the NIH grants guide at the link provided in the source data (http://grants.nih.gov/grants/guide/pa-files/PA-13-079.html), and the NIH Office of Extramural Research (OER) webmaster contact was provided for access or technical issues related to the announcement.
Frequently Asked Questions (FAQs)
What is the Behavioral Integrative Treatment Development Program (R03)?
The Behavioral Integrative Treatment Development Program (R03) was a discretionary National Institutes of Health (NIH) funding opportunity (Funding Opportunity Number PA-13-079) that supported small, clearly defined research projects focused on behavioral interventions and integrative approaches (for example, combining behavioral strategies with other modalities such as pharmacological treatment).
What type of NIH grant mechanism did this opportunity use?
This opportunity used the NIH R03 mechanism, which is intended for small research projects with a limited scope and duration, rather than large, multi-year clinical trials.
How long could projects last under this FOA?
Projects supported under this FOA were designed to be completed within a two-year period.
What was the maximum award amount?
The maximum award amount listed for PA-13-079 was $100,000.
Was cost sharing or matching required?
No. The FOA stated there was no cost sharing or matching requirement.
What was the main goal of this funding opportunity?
The central goal was to stimulate research on behavioral interventions or integrated approaches that combine behavioral strategies with other modalities, including pharmacological treatment, in high-priority public health areas related to drug abuse, HIV prevention in treatment contexts, treatment and medication adherence, and chronic pain.
What research topics and public health areas were highlighted?
The FOA highlighted research focused on drug abuse (including common co-occurring conditions), prevention of HIV acquisition or transmission among people in drug abuse treatment, improving adherence to drug abuse treatment and to HIV or addiction medications, and interventions relevant to chronic pain.
What kinds of projects did the FOA emphasize?
The FOA emphasized early-stage or targeted studies suitable for the R03 mechanism, including pilot work, intervention development, and preparatory research intended to lay groundwork for later, larger-scale grants.
What does "Stage I behavioral intervention development" mean in this FOA?
In this FOA, Stage I behavioral intervention development referred to early work such as generating and shaping new interventions (Stage I intervention generation) and conducting early pilot or feasibility testing (Stage I pilot/feasibility studies) to assess practicality, acceptability, and initial promise.
Did the FOA encourage pilot or feasibility studies?
Yes. The FOA specifically highlighted Stage I pilot or feasibility studies as examples of the types of projects it sought to support.
Were applicants expected to study how and for whom an intervention works?
Yes. The FOA encouraged early-stage projects to incorporate work on potential moderators, mediators, and mechanisms of change, meaning studies should consider not only whether an intervention may work, but also for whom, under what conditions, and through what processes it produces change.
Did the FOA support adapting interventions for primary care settings?
Yes. The FOA encouraged Stage I studies that adapt or refine drug abuse treatment or adherence interventions for use in primary care settings, reflecting interest in real-world healthcare environments.
Was technology use or improving implementability part of the priorities?
Yes. The FOA prioritized strengthening the impact and practicality of interventions by improving their implementability, including through creative uses of technology or other strategies to increase reach, consistency, or scalability.
Which organizations were eligible to apply?
Eligibility was broad and included many types of organizations across the public, private, nonprofit, and educational sectors.
Were government entities eligible applicants?
Yes. Eligible applicants included federal, state, county, city, and township governments, as well as special district governments.
Were colleges and universities eligible?
Yes. Public and private institutions of higher education were eligible applicants.
Were nonprofit organizations eligible (including those without 501(c)(3) status)?
Yes. The FOA included nonprofits with and without 501(c)(3) status (other than institutions of higher education) among eligible applicants.
Could for-profit organizations apply?
Yes. Small businesses and other for-profit organizations were eligible, including organizations that are not small businesses.
Were tribal governments and tribal organizations eligible?
Yes. Eligibility included Native American tribal governments and organizations, including federally recognized tribal governments and other tribal entities.
Did the FOA call out specific types of institutions (HBCUs, HSIs, TCCUs, etc.)?
Yes. The FOA explicitly noted eligibility for organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations, among others.
Were U.S. territories or regional organizations eligible?
Yes. The FOA noted U.S. territories or possessions and regional organizations among eligible applicant types.
Could non-U.S. entities apply?
Yes. The FOA allowed non-U.S. entities to apply, including foreign organizations and foreign institutions, and it permitted foreign components as defined by NIH policy.
When was PA-13-079 posted and when did it close?
The opportunity was posted/created on January 9, 2013. The original and final closing date was January 7, 2016.
Is this funding opportunity still active?
No. The FOA was archived on February 7, 2016.
What CFDA numbers were associated with this FOA?
The FOA listing associated it with CFDA 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs).
Where could applicants find the full announcement?
The full announcement was available via the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PA-13-079.html.
Who was listed as a contact for access or technical issues?
The NIH Office of Extramural Research (OER) webmaster contact was provided for access or technical issues related to the announcement.
Browse more opportunities from the same category: Education Health
Next opportunity: Indoor Environment of Low Income Renovated Multifamily Housing in the Western Region of the United States
Previous opportunity: Behavioral Integrative Treatment Development Program (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 079
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 079) also looked into and applied for these:
| Funding Opportunity |
|---|
| Accelerating the Pace of Drug Abuse Research Using Existing Data (R01) Apply for PAR 13 080 Funding Number: PAR 13 080 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Bridging the Gap Between Cancer Mechanism and Population Science (U01) Apply for PAR 13 081 Funding Number: PAR 13 081 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25) Apply for PAR 13 084 Funding Number: PAR 13 084 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 13 086 Funding Number: PAR 13 086 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Apply for PAR 13 087 Funding Number: PAR 13 087 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Planning for a National Center for Particle Beam Radiation Therapy Research (P20) Apply for PAR 13 096 Funding Number: PAR 13 096 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| NCI Experimental Therapeutics Clinical Trials Network with Phase 1 Emphasis (ET CTN) (UM1) Apply for RFA CA 13 006 Funding Number: RFA CA 13 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $850,000 |
| The Influence of the Microbiome on Preterm Labor and Delivery (R01) Apply for RFA NR 13 002 Funding Number: RFA NR 13 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| The Influence of the Microbiome on Preterm Labor and Delivery (R21) Apply for RFA NR 13 003 Funding Number: RFA NR 13 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Collaborative Human Tissue Network (CHTN) (UM1) Apply for RFA CA 13 007 Funding Number: RFA CA 13 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,200,000 |
| Research on Marijuana Legalization in the US (Admin Supp) Apply for PA 13 138 Funding Number: PA 13 138 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 13 004 Funding Number: RFA OD 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Multicenter AIDS Cohort Study Center for the Coordination, Analysis, and Management of the MACS (CAMACS)(UM1) Apply for RFA AI 13 010 Funding Number: RFA AI 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,400,000 |
| Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01) Apply for RFA AI 13 011 Funding Number: RFA AI 13 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $4,200,000 |
| Limited Competition Scholars Training for the Advancement of Research (STAR) Revision to NINR T32 Training Grants (T32) Apply for RFA NR 13 010 Funding Number: RFA NR 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 13 146 Funding Number: PAR 13 146 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 14 003 Funding Number: RFA DA 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 13 157 Funding Number: PA 13 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $175,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21/R33) Apply for PAR 13 158 Funding Number: PAR 13 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 13 163 Funding Number: PAR 13 163 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 079", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.